Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 04, 2017
FDA Warns Against Company's Unsafe Teething Tablets
On June 20, 2017, the FDA issued a warning letter to Raritan Pharmaceuticals, Inc. following a routine inspection of the facility when it found the company's Homeopathic Infant's Teething Tablets in violation of current good manufacturing practice (CGMP) regulations.
Join today to unlock all member benefits including full access to all recalls & warnings
Join NowAlready a member? Sign In Here.
Join now at www.consumerlab.com/join/